Thompson, Marin E.
Harvard University · University of Pittsburgh · University of California, San Francisco · Massachusetts General Hospital · Voyager Therapeutics (United States) · University of Pittsburgh Medical Center · The Ohio State University · Neurocrine Biosciences (United States)
2 papers on CoChat
Most cited papers
- Verified
Magnetic resonance imaging–guided phase 1 trial of putaminal AADC gene therapy for Parkinson's disease
Christine, C. W., Bankiewicz, K. S., Van Laar, A. D., Richardson, R. M., Ravina, B., Kells, A. P., Boot, B., Martin, A. J., Nutt, J., Thompson, M. E., et al. (2019) · Annals of Neurology
Virus-based gene therapy researchParkinson's Disease Mechanisms and Treatments
Cited by 167
- Verified
Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial
Christine, C. W., Richardson, R. M., Van Laar, A. D., Thompson, M. E., Fine, E. M., Khwaja, O. S., Li, C., Liang, G. S., Meier, A., Roberts, E. W., et al. (2022) · Neurology
Parkinson's Disease Mechanisms and TreatmentsVirus-based gene therapy research
Cited by 89
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free